Freshfields and Links partners among 500 lawyers drafted in on GSK JV with Novartis
Partners at Linklaters and Freshfields Bruckhaus Deringer are among the 500 lawyers to have cashed in on the billion-dollar joint venture between Novartis and GlaxoSmithKline (GSK). The pharmaceutical giants will swap assets as part of the deal, with GSK acquiring Novartis’ global vaccines unit, excluding its flu division, for $7.1bn. Novartis will take on GSK’s […]